Bioblast Pharma Ltd. (ORPN)

18.50
0.09 0.48
NASDAQ : Health Technology
Prev Close 18.59
Open 19.44
Day Low/High 18.31 / 19.44
52 Wk Low/High 6.19 / 20.48
Volume 18.44K
Avg Volume 162.30K
Exchange NASDAQ
Shares Outstanding 420.00K
Market Cap 4.83M
EPS -14.30
P/E Ratio N/A
Div & Yield N.A. (N.A)
Bioblast Pharma To Host Key Opinion Leader Lunch Focused On Orphan Neurological Diseases On February 2

Bioblast Pharma To Host Key Opinion Leader Lunch Focused On Orphan Neurological Diseases On February 2

Investor Lunch and Live Webcast at 12 Noon Eastern Time on February 2

5 Stocks to Trade for Big Breakout Gains

5 Stocks to Trade for Big Breakout Gains

These five stocks could be toxic for your portfolio in the month ahead.

7 Stocks Under $10 to Trade for Big Profits

7 Stocks Under $10 to Trade for Big Profits

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

BioBlast Pharma To Present Final HOPEMD Phase 2 Clinical Study Results Of Trehalose In Oculopharyngeal Muscular Dystrophy At The American Academy Of Neurology (AAN) 2016 Annual Meeting

BioBlast Pharma To Present Final HOPEMD Phase 2 Clinical Study Results Of Trehalose In Oculopharyngeal Muscular Dystrophy At The American Academy Of Neurology (AAN) 2016 Annual Meeting

Final Results of 24-Week Open-Label Phase 2 Trial Will be Presented by Professor Zohar Argov, MD, Senior Medical Advisor to BioBlast Pharma

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks are within range of triggering big breakouts.

BioBlast Pharma Enhances Leadership Team

BioBlast Pharma Enhances Leadership Team

Appoints Industry Veteran, Robert W. Cook, as Chief Financial Officer